Subscribe To
Vertex needs to sell or make a big acquisition
Should investors holding shares of Vertex pharmaceuticals Incorporated ( VRTX , Financial) follow the a...
October 6, 2021, 3:51 pm
Vertex needs to sell or make a big acquisition
Should investors holding shares of Vertex pharmaceuticals Incorporated ( VRTX , Financial) follow the a...
October 6, 2021, 3:51 pm
Vertex needs to sell or make a big acquisition
Should investors holding shares of Vertex pharmaceuticals Incorporated ( VRTX , Financial) follow the a...
October 6, 2021, 3:51 pm
Why bofa turned bullish on checkmate pharmaceuticals, but slashed price target
Given the early clinical data on Checkmate pharmaceuticals Inc's (NASDAQ:CMPI) vidutolimod, key opinio...
October 6, 2021, 3:27 pm
Why bofa turned bullish on checkmate pharmaceuticals, but slashed price target
Given the early clinical data on Checkmate pharmaceuticals Inc's (NASDAQ:CMPI) vidutolimod, key opinio...
October 6, 2021, 3:27 pm
Why bofa turned bullish on checkmate pharmaceuticals, but slashed price target
Given the early clinical data on Checkmate pharmaceuticals Inc's (NASDAQ:CMPI) vidutolimod, key opinio...
October 6, 2021, 3:27 pm
Catalyst pharmaceuticals stock reaches resistance level, looks ready to break out
Catalyst pharmaceuticals Inc. (NASDAQ:CPRX) shares are trading higher Wednesday although there looks to...
October 6, 2021, 2:50 pm
Catalyst pharmaceuticals stock reaches resistance level, looks ready to break out
Catalyst pharmaceuticals Inc. (NASDAQ:CPRX) shares are trading higher Wednesday although there looks to...
October 6, 2021, 2:50 pm
Catalyst pharmaceuticals stock reaches resistance level, looks ready to break out
Catalyst pharmaceuticals Inc. (NASDAQ:CPRX) shares are trading higher Wednesday although there looks to...
October 6, 2021, 2:50 pm
U.s. justice antitrust nominee says eager to tackle more than just big tech
Jonathan Kanter, the third of three progressives named to top U.S. antitrust posts by President Joe Biden, pledged on Wednesday to enforce antitrust l...
October 6, 2021, 2:13 pm
U.s. justice antitrust nominee says eager to tackle more than just big tech
Jonathan Kanter, the third of three progressives named to top U.S. antitrust posts by President Joe Biden, pledged on Wednesday to enforce antitrust l...
October 6, 2021, 2:13 pm
U.s. justice antitrust nominee says eager to tackle more than just big tech
Jonathan Kanter, the third of three progressives named to top U.S. antitrust posts by President Joe Biden, pledged on Wednesday to enforce antitrust l...
October 6, 2021, 2:13 pm
Flora growth sets up a new division to develop data-backed pharmaceutical cannabis products
Flora Growth Corp (NASDAQ: FLGC) set up a new division it's calling Flora Pharma to begin scientific clinical trials globally, the Canadian cannabis c...
October 6, 2021, 12:24 pm
Flora growth sets up a new division to develop data-backed pharmaceutical cannabis products
Flora Growth Corp (NASDAQ: FLGC) set up a new division it's calling Flora Pharma to begin scientific clinical trials globally, the Canadian cannabis c...
October 6, 2021, 12:24 pm
Flora growth sets up a new division to develop data-backed pharmaceutical cannabis products
Flora Growth Corp (NASDAQ: FLGC) set up a new division it's calling Flora Pharma to begin scientific clinical trials globally, the Canadian cannabis c...
October 6, 2021, 12:24 pm
Viatris is cheap
Viatris Inc. ( VTRS , Financial) was formed by the combination of generic pharmaceutical company Mylan ...
October 6, 2021, 11:50 am
Viatris is cheap
Viatris Inc. ( VTRS , Financial) was formed by the combination of generic pharmaceutical company Mylan ...
October 6, 2021, 11:50 am
Viatris is cheap
Viatris Inc. ( VTRS , Financial) was formed by the combination of generic pharmaceutical company Mylan ...
October 6, 2021, 11:50 am
Bofa downgrades takeda on suspension narcolepsy drug trials
Takeda pharmaceutical Co Ltd (NYSE:TAK) announced the suspension of the Phase II trials of its narcolep...
October 6, 2021, 11:35 am
Bofa downgrades takeda on suspension narcolepsy drug trials
Takeda pharmaceutical Co Ltd (NYSE:TAK) announced the suspension of the Phase II trials of its narcolep...
October 6, 2021, 11:35 am